ASPI News
Archived Headlines
- US IPO Week Ahead: Mobileye grabs headlines in an otherwise quiet week 10/21/22
- US IPO Week Ahead: Gene editing biotech plots the first $100+ million IPO of the 4Q 10/14/22
- Advanced materials company ASP Isotopes sets terms for $12 million IPO 10/11/22
- US IPO Weekly Recap: Billion-dollar deal Corebridge completes 2022’s largest IPO to date 09/16/22
- Advanced materials company ASP Isotopes files for a $30 million IPO 09/12/22
Renaissance Capital's November IPO Market Update
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more
US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week
Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two...read more
Isotope enrichment company ASP Isotopes prices further downsized IPO at $4 low end
ASP Isotopes, which is developing isotope enrichment facilities for medical and energy applications, raised $5 million by offering 1.3 million shares at $4, the low end of the downwardly revised range of $4 to $5. The company offered 0.3 million fewer...read more
Isotope enrichment company ASP Isotopes cuts deal size by 44% ahead of $7 million IPO
ASP Isotopes, which is developing isotope enrichment facilities for medical and energy applications, lowered the proposed deal size for its upcoming IPO on Monday. The Boca Raton, FL-based company now plans to raise $7 million by offering 1.5 million shares at...read more